Showing 1291-1300 of 8079 results for "".
Nonverbal Communication in the Patient Consultation
https://practicaldermatology.com/topics/practice-management/1109_07-php/22059/Recognition of the most common body language cues can help you understand what your patients may be thinking but not saying out loud.Challenges and Opportunities for the Dermatology Specialty
https://practicaldermatology.com/topics/practice-management/challenges-and-opportunities-for-the-dermatology-specialty/23881/Joining together may help address some of the issues facing board-certified dermatologists.Case Study: Recurrent Generalized Pustular Psoriasis
https://practicaldermatology.com/issues/august-2025/recurrent-generalized-pustular-psoriasis/36711/This article reports the case of a 74-year-old white man with a history of psoriatic arthritis and congestive heart failure who presented with two separate episodes of GPP. Both of these episodes were associated with hypocalcemia and required inpatient hospitalization.Next Generation Retinoids
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/next-generation-retinoids/23599/The search for a more tolerable retinoid has led to study of unique delivery systems, novel retinoid molecules, and even botanicals.A Growing Biologics Armamentarium for Psoriasis and Atopic Dermatitis
https://practicaldermatology.com/topics/psoriasis/a-growing-biologics-armamentarium-for-psoriasis-and-atopic-dermatitis/20660/An overview of effective and safe treatment options that continue to come to market to target these chronic conditions.Cannabinoid Photo-Rejuvenation: A Clinico-Pathologic Study
https://practicaldermatology.com/topics/feature/cannabinoid-photo-rejuvenation-a-clinico-pathologic-study/29188/In this study, we sought to assess the effectiveness of a novel topical formulation containing CBD isolate, resveratrol, thyme extract, caffeine, and lecithin in reversing photodamage over a 90-day treatment period.Diverse by Design: The Unique Molecular Footprints of IL-23 Biologics in Psoriasis
https://practicaldermatology.com/issues/april-2024/il23_biologics_in_psoriasis/24457/Christopher Bunick, MD, PhD, discusses a study that explores the structural basis of IL-23 targeted biologic therapies for psoriasis. By mapping the binding sites of these therapies on the IL-23 molecule and correlating molecular properties with clinical efficacy, the study offers insights into whyNew In My Practice: Cosmeceutical
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-cosmeceutical-1/23986/Merz Aesthetics’ Neocutis Neo Restore Post Treatment Nourishing Sheet MaskA Peak Inside the Psoriasis Pipeline
https://practicaldermatology.com/columns/clinical-focus-1/special-edition-what-i-did-on-my-summer-vacation/23803/Here’s a look at what’s here today and what is coming down the pike for psoriasis patients.A Growing Neuromodulator Market: Daxxify Approved
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/a-growing-neuromodualtor-market-daxxify-approved/23797/Revance Therapeutics’ DaxibotulinumtoxinA-lanm is now approved to treat glabellar lines.